← brief for 2026-09-30 · Slowing decline

SGLT2 inhibitors: mechanisms, physiology and pharmacology, and clinical applications.

Key takeaways

This review explains how a common diabetes drug works in the body. It describes how the drug changes kidney function and blood flow. It does not report new trial results. It is a summary of what is already known about the drug.

Who did this work

Zheng XT · Xie HY · Wang XH · Zhao Y · Yang JY · Liu YX · Yuan XL · Tang HF · Jiang ZS · Hu HJ

Source

Paper · PubMed, the drug frontier · 2026 Sep 30
https://pubmed.ncbi.nlm.nih.gov/42814168/